Document is current

Article History

Received: 12 November 2025

Accepted: 27 June 2026

First Online: 8 July 2026

Declarations

:

: Our research was conducted entirely in accordance with the Declaration of Helsinki for Medical Research. This study was ethically approved by the UK Clinical Practice Research Datalink (CPRD) RDG under protocol number 23_003371, “Association between COVID-19 and new onset of diabetes”.

: This work uses data provided by patients and collected by the NHS as part of their care and support. The patients whose data was used in this study gave their informed consent for the data to be used for research purposes as part of the UK Clinical Practice Research Datalink (CPRD).

: This work adheres to STROBE guidelines for reporting observational studies [ ]. A completed STROBE checklist can be found in the Supplementary Materials.

: Professor Prieto-Alhambra’s research group has received funding from the European Medicines Agency and Innovative Medicines Initiative. DPA’s group received partial support from the Oxford NIHR Biomedical Research Centre. DPA’s research group from the University of Oxford has received research grants from the Innovative Medicines Initiative, from Gilead Science, from Theramex, and from UCB Biopharma, none of which are related to this manuscript.